EDGAR Filing Documents for 0000950144-06-002317

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:

SEC Accession No. 0000950144-06-002317

Filing Date

2006-03-15

Accepted

2006-03-15 16:31:27

Documents

Period of Report

2005-12-31

Document Format Files

Seq	Description	Document	Type	Size
1	NOVEN PHARMACEUTICALS INC.	g00133e10vk.htm	10-K	1096104
2	AGREEMENT WITH SHIRE PHARMACEUTICALS IRELAND LTD.	g00133exv10w27.htm	EX-10.27	12261
3	TERMINATION AGREEMENT WITH ENDO PHARMACEUTICALS	g00133exv10w30.htm	EX-10.30	14604
4	COMPUTATION OF EARNINGS PER SHARE	g00133exv11.htm	EX-11	12367
5	SUBSIDIARIES OF THE REGISTRANT	g00133exv21.htm	EX-21	1730
6	CONSENT OF DELOITTE & TOUCHE LLP	g00133exv23w1.htm	EX-23.1	1699
7	CONSENT OF PRICEWATERHOUSECOOPERS LLP	g00133exv23w2.htm	EX-23.2	1368
8	SECTION 302 CHIEF EXECUTIVE OFFICER CERTIFICATION	g00133exv31w1.htm	EX-31.1	5144
9	SECTION 302 CHIEF FINANCIAL OFFICER CERTIFICATION	g00133exv31w2.htm	EX-31.2	5103
10	SECTION 906 CHIEF EXECUTIVE OFFICER CERTIFICATION	g00133exv32w1.htm	EX-32.1	2825
11	SECTION 906 CHIEF FINANCIAL OFFICER CERTIFICATION	g00133exv32w2.htm	EX-32.2	2664
	Complete submission text file	0000950144-06-002317.txt		1157248

Mailing Address 11960 SW 144TH STREET MIAMI FL 33185

Business Address 11960 SW 144TH ST MIAMI FL 33186 3052535099

NOVEN PHARMACEUTICALS INC (Filer) CIK: 0000815838 (see all company filings)